BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9272766)

  • 1. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.
    Arnone M; Maruani J; Chaperon F; Thiébot MH; Poncelet M; Soubrié P; Le Fur G
    Psychopharmacology (Berl); 1997 Jul; 132(1):104-6. PubMed ID: 9272766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice.
    Poncelet M; Maruani J; Calassi R; Soubrié P
    Neurosci Lett; 2003 Jun; 343(3):216-8. PubMed ID: 12770700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of SR141716A on ethanol and sucrose self-administration.
    Freedland CS; Sharpe AL; Samson HH; Porrino LJ
    Alcohol Clin Exp Res; 2001 Feb; 25(2):277-82. PubMed ID: 11236843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats.
    Economidou D; Mattioli L; Cifani C; Perfumi M; Massi M; Cuomo V; Trabace L; Ciccocioppo R
    Psychopharmacology (Berl); 2006 Jan; 183(4):394-403. PubMed ID: 16261315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.
    Simiand J; Keane M; Keane PE; Soubrié P
    Behav Pharmacol; 1998 Mar; 9(2):179-81. PubMed ID: 10065938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716.
    Colombo G; Agabio R; Fà M; Guano L; Lobina C; Loche A; Reali R; Gessa GL
    Alcohol Alcohol; 1998; 33(2):126-30. PubMed ID: 9566474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
    Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
    Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of SR141716 on post-reinforcement pauses in operant responding for sucrose reward in rats.
    Pério A; Barnouin MC; Poncelet M; Soubrié P
    Behav Pharmacol; 2001 Dec; 12(8):641-5. PubMed ID: 11856902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study.
    Freedland CS; Whitlow CT; Smith HR; Porrino LJ
    Brain Res; 2003 Feb; 962(1-2):169-79. PubMed ID: 12543468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat.
    Gueudet C; Santucci V; Rinaldi-Carmona M; Soubrié P; Le Fur G
    Neuroreport; 1995 Jul; 6(10):1421-5. PubMed ID: 7488739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.
    Mansbach RS; Rovetti CC; Winston EN; Lowe JA
    Psychopharmacology (Berl); 1996 Apr; 124(4):315-22. PubMed ID: 8739546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist.
    Gallate JE; Saharov T; Mallet PE; McGregor IS
    Eur J Pharmacol; 1999 Apr; 370(3):233-40. PubMed ID: 10334497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats.
    Costa B; Vailati S; Colleoni M
    Behav Pharmacol; 1999 May; 10(3):327-31. PubMed ID: 10780247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
    Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cannabinoid CB(1) receptor antagonist rimonabant (SR-141716) on ethanol drinking in high-preferring rats.
    Dyr W; Ligieza J; Kostowski W
    Alcohol; 2008 Sep; 42(6):509-12. PubMed ID: 18504086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.
    Rinaldi-Carmona M; Pialot F; Congy C; Redon E; Barth F; Bachy A; Brelière JC; Soubrié P; Le Fur G
    Life Sci; 1996; 58(15):1239-47. PubMed ID: 8614277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats.
    Rowland NE; Mukherjee M; Robertson K
    Psychopharmacology (Berl); 2001 Dec; 159(1):111-6. PubMed ID: 11797078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.
    Navarro M; Hernández E; Muñoz RM; del Arco I; Villanúa MA; Carrera MR; Rodríguez de Fonseca F
    Neuroreport; 1997 Jan; 8(2):491-6. PubMed ID: 9080435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine.
    Masserano JM; Karoum F; Wyatt RJ
    Behav Pharmacol; 1999 Jul; 10(4):429-32. PubMed ID: 10780811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.
    Terranova JP; Storme JJ; Lafon N; Péŕio A; Rinaldi-Carmona M; Le Fur G; Soubrié P
    Psychopharmacology (Berl); 1996 Jul; 126(2):165-72. PubMed ID: 8856836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.